Product Information
TRI-LO-MARZIA TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1083 per EA under NDC 68180083773. Its NADAC has been published 342 times since Feb 5, 2020.
FDA first approved this application on Jun 25, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180083773
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA200541FDA Approved
6/25/2012
TE Code
AB
On Market Since
1/8/2020
Price Statistics
The NADAC for TRI-LO-MARZIA TABLET has been published 342 times since Feb 5, 2020, and over the history we have for it it has declined 48.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1083 per EA |
|---|---|
| All-time high | $0.2385 (Aug 12, 2020) |
| All-time low | $0.0903 (Nov 20, 2024) |
| 52-week high | $0.1148 |
| 52-week low | $0.1046 |
| Median price | $0.1534 |
| Average price | $0.1488 |
| Largest weekly change | -27.8% (Apr 17, 2024) |
| Weeks tracked | 342 |
| Tracking since | Feb 5, 2020 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRI-LO-MARZIA TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRI-LO-MARZIA TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.1083 per EA (NDC 68180083773), effective Aug 19, 2026.
How has the price of TRI-LO-MARZIA TABLET changed over time?
Over the history we have for it, the NADAC for TRI-LO-MARZIA TABLET has declined 48.6%. It has been tracked across 342 weekly CMS publications since Feb 5, 2020.
What are the highest and lowest recorded NADAC prices for TRI-LO-MARZIA TABLET?
Since Feb 5, 2020, the NADAC for TRI-LO-MARZIA TABLET has ranged from a low of $0.0903 (Nov 20, 2024) to a high of $0.2385 (Aug 12, 2020), with a median of $0.1534 per EA.
Are there cheaper alternatives to TRI-LO-MARZIA TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TRI-LO-MARZIA TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TRI-LO-MARZIA TABLET?
TRI-LO-MARZIA TABLET (NDC 68180083773) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.